Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Market Cap	16.41B -30.8%
Revenue (ttm)	14.90B +2.3%
Net Income	1.79B -22.0%
EPS	0.39 -21.1%
Shares Out	4.52B
PE Ratio	9.19
Forward PE	8.32
Dividend	0.18 (4.96%)
Ex-Dividend Date	Jun 2, 2026

Volume	26,046,600
Average Volume	32,447,762
Open	3.650
Previous Close	3.630
Day's Range	3.650 - 3.710
52-Week Range	3.550 - 7.390
Beta	0.41
RSI	32.38
Earnings Date	Mar 27, 2026

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1988
• Employees: 13,307
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1066

Financial Performance

In 2025, HKG:1066's revenue was 13.39 billion, an increase of 2.31% compared to the previous year's 13.09 billion. Earnings were 1.61 billion, a decrease of -21.99%.

Financial numbers in CNY